Cargando…

Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015

BACKGROUND: Disease modifying treatments (DMTs) are the main responsible for direct medical costs in multiple sclerosis (MS). The current investigation aims at evaluating possible associations between healthcare costs for treating relapsing remitting MS (RRMS) and disease evolution. METHODS: The pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moccia, Marcello, Palladino, Raffaele, Lanzillo, Roberta, Carotenuto, Antonio, Russo, Cinzia Valeria, Triassi, Maria, Brescia Morra, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215923/ https://www.ncbi.nlm.nih.gov/pubmed/28056103 http://dx.doi.org/10.1371/journal.pone.0169489

Ejemplares similares

Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)
por: Moccia, Marcello, et al.
Publicado: (2020)

Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare data
por: Moccia, Marcello, et al.
Publicado: (2021)

Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015–2017 Prevalence
por: Moccia, Marcello, et al.
Publicado: (2020)

COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak
por: Buonomo, Antonio, et al.
Publicado: (2020)

Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy
por: Moccia, Marcello, et al.
Publicado: (2022)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2021)

Determinants of early working impairments in multiple sclerosis
por: Moccia, Marcello, et al.
Publicado: (2022)

Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study
por: Affinito, Giuseppina, et al.
Publicado: (2023)

Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic Review
por: De Angelis, Marcello, et al.
Publicado: (2021)

Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials
por: Moccia, Marcello, et al.
Publicado: (2020)

Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis
por: Petracca, Maria, et al.
Publicado: (2021)

Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10
por: Moccia, Marcello, et al.
Publicado: (2019)

Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis
por: Caliendo, Daniele, et al.
Publicado: (2023)

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery
por: Moccia, Marcello, et al.
Publicado: (2019)

Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice
por: De Angelis, Marcello, et al.
Publicado: (2020)

Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis
por: Moccia, Marcello, et al.
Publicado: (2019)

Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2019)

Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg
por: Capasso, Nicola, et al.
Publicado: (2020)

Prevalence of SARS-CoV-2 antibodies in multiple sclerosis: The hidden part of the iceberg
por: Capasso, Nicola, et al.
Publicado: (2021)

Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study
por: Capasso, Nicola, et al.
Publicado: (2022)

Epidemiological and Immune Profile Analysis of Italian Subjects with Endometriosis and Multiple Sclerosis
por: Zizolfi, Brunella, et al.
Publicado: (2023)

A Retrospective Exploratory Analysis on Cardiovascular Risk and Cognitive Dysfunction in Multiple Sclerosis
por: Reia, Antonio, et al.
Publicado: (2021)

Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience
por: Rosa, Laura, et al.
Publicado: (2022)

Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis
por: Cassiano, Maria Teresa, et al.
Publicado: (2020)

Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series
por: Moccia, Marcello, et al.
Publicado: (2022)

Retinal and Choriocapillary Vascular Changes in Early Stages of Multiple Sclerosis: A Prospective Study
por: Montorio, Daniela, et al.
Publicado: (2021)

Cognitive trajectories in multiple sclerosis: a long-term follow-up study
por: Carotenuto, Antonio, et al.
Publicado: (2021)

Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
por: Novarella, Federica, et al.
Publicado: (2022)

Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis
por: Cennamo, Gilda, et al.
Publicado: (2020)

A two-year longitudinal study of retinal vascular impairment in patients with amnestic mild cognitive impairment
por: Criscuolo, Chiara, et al.
Publicado: (2022)

Corrigendum: A two-year longitudinal study of retinal vascular impairment in patients with amnestic mild cognitive impairment
por: Criscuolo, Chiara, et al.
Publicado: (2023)

Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study
por: Comi, Giancarlo, et al.
Publicado: (2020)

A voxel-based morphometry study of disease severity correlates in relapsing–remitting multiple sclerosis
por: Prinster, A, et al.
Publicado: (2010)

Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions
por: Vola, Elena Augusta, et al.
Publicado: (2021)

JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level
por: Lanzillo, Roberta, et al.
Publicado: (2014)

Internal Jugular Vein Blood Flow in Multiple Sclerosis Patients and Matched Controls
por: Mancini, Marcello, et al.
Publicado: (2014)

Social Media and Multiple Sclerosis in the Posttruth Age
por: Lavorgna, Luigi, et al.
Publicado: (2017)

Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study
por: Rosa, Laura, et al.
Publicado: (2022)

Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis
por: Ugga, Lorenzo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g7mm4s1tb8m8hocm2dopsjit9o